We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$80.5B
AUM Growth
-$3.46B
(-4.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
13.64%
Holding
817
New
51
Increased
266
Reduced
358
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$499M |
| 2 |
Fidelity National Information Services
FIS
|
+$462M |
| 3 |
Honeywell
HON
|
+$367M |
| 4 |
Lennar Class A
LEN
|
+$321M |
| 5 |
Extra Space Storage
EXR
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$486M |
| 2 |
Global Payments
GPN
|
+$421M |
| 3 |
Eaton
ETN
|
+$415M |
| 4 |
Dell
DELL
|
+$391M |
| 5 |
Howmet Aerospace
HWM
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.82% |
| 2 | Technology | 16.67% |
| 3 | Industrials | 16.22% |
| 4 | Healthcare | 11.1% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ameriprise Financial
AMP
$49.1B
| $626M | 0.78% |
1,465,915
-82,520
| -5% | -$35.3M |
|
27
CRH
CRH
$63.6B
| $620M | 0.77% |
8,248,433
+734,781
| +10% | +$58.6M |
|
28
Goldman Sachs
GS
$303B
| $612M | 0.76% |
1,350,457
-5,736
| -0.4% | -$2.52M |
|
29
Masco
MAS
$14.4B
| $605M | 0.75% |
9,069,025
+1,135,414
| +14% | +$80M |
|
30
Textron
TXT
$14.2B
| $603M | 0.75% |
7,024,291
-91,940
| -1% | -$8.18M |
|
31
Coca-Cola Europacific Partners
CCEP
$47.4B
| $596M | 0.74% |
8,182,353
+469,885
| +6% | +$33.8M |
|
32
Philip Morris
PM
$297B
| $591M | 0.73% |
5,824,419
-24,977
| -0.4% | -$2.44M |
|
33
SLB Ltd
SLB
$81.6B
| $590M | 0.73% |
12,510,955
+870,128
| +7% | +$42M |
|
34
CenterPoint Energy
CNP
$25.9B
| $590M | 0.73% |
19,037,480
+1,491,952
| +9% | +$44M |
|
35
Check Point Software Technologies
CHKP
$13.6B
| $589M | 0.73% |
3,571,735
-52,188
| -1% | -$8.13M |
|
36
Leidos
LDOS
$17.6B
| $583M | 0.72% |
3,990,280
+560,016
| +16% | +$78.3M |
|
37
Applied Materials
AMAT
$383B
| $568M | 0.71% |
2,408,083
-12,438
| -0.5% | -$2.67M |
|
38
Chubb
CB
$131B
| $558M | 0.69% |
2,187,690
+40,029
| +2% | +$10.3M |
|
39
Jacobs Solutions
J
$17.6B
| $548M | 0.68% |
4,739,477
+269,811
| +6% | +$31.6M |
|
40
Centene
CNC
$32.3B
| $545M | 0.68% |
8,219,518
-432,659
| -5% | -$31.5M |
|
41
Ametek
AME
$55.9B
| $545M | 0.68% |
3,267,741
+204,153
| +7% | +$35.3M |
|
42
Cigna
CI
$73.4B
| $536M | 0.67% |
1,619,375
-1,659
| -0.1% | -$572K |
|
43
LPL Financial
LPLA
$28.4B
| $527M | 0.65% |
1,887,189
+121,959
| +7% | +$33.1M |
|
44
Fortive
FTV
$18.1B
| $506M | 0.63% |
9,063,032
+485,607
| +6% | +$28.2M |
|
45
ConocoPhillips
COP
$156B
| $504M | 0.63% |
4,406,203
-45,593
| -1% | -$5.54M |
|
|
FITB
46
Fifth Third Bancorp
FITB
$49.7B
| $501M | 0.62% |
13,741,059
+50,907
| +0.4% | +$1.86M |
|
47
Allegion
ALLE
$13.6B
| $497M | 0.62% |
4,201,836
-804,389
| -16% | -$99.1M |
|
48
American Express
AXP
$226B
| $493M | 0.61% |
2,125,335
-3,840
| -0.2% | -$889K |
|
49
Take-Two Interactive
TTWO
$43.6B
| $487M | 0.61% |
3,133,662
+436,014
| +16% | +$66.1M |
|
50
Booking.com
BKNG
$152B
| $483M | 0.6% |
3,051,450
-47,700
| -2% | -$7.07M |
|
Similar funds
Boston Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Boston Partners held 817 positions worth $80.5B, down 4.1% from $84B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q2 2024 filing shows 51 new, 266 increased, 358 reduced and 117 closed positions. Its largest new stake was Honeywell: 1,930,615 shares worth $389M. The largest sale was Sanofi, an estimated $486M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q2 2024 buy was Honeywell: 1,930,615 shares worth $389M.
- Boston Partners added most to AbbVie in Q2 2024, an estimated $499M increase.
- Boston Partners's biggest Q2 2024 reduction was Sanofi, cutting an estimated $486M.
- Boston Partners fully exited Globe Life in Q2 2024, selling an estimated $243M.
- Boston Partners's ten largest holdings make up 14% of its $80.5B portfolio in Q2 2024.
- Boston Partners opened 51 new positions and closed 117 in Q2 2024.
- Boston Partners's portfolio value fell 4.1% quarter-over-quarter to $80.5B.
Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.